Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of rifapentine-carried polycaprolactone microspheres

A technology of rifapentine microspheres and polycaprolactone, which is used in pharmaceutical formulations, microcapsules, bone diseases, etc., can solve the problems of poor product preparation effect, poor antibacterial properties, and low drug loading, and achieves round shape. , High drug loading, good sustained release effect

Inactive Publication Date: 2017-02-22
SHAANXI YIPINDA PETROCHEM CO LTD
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, there are few studies on the use of polycaprolactone to load rifapentine to construct long-acting microsphere sustained-release systems, and the preparation of products has poor effect, low drug loading, and poor antibacterial properties.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] The preparation method of polycaprolactone-loaded rifapentine microspheres comprises the following steps:

[0018] (1) Weigh 10-50 mg of the original drug of rifapentine and 200-300 mg of polycaprolactone and dissolve them in 10-15 mL of dichloromethane, and ultrasonically treat them to form an oil phase;

[0019] (2) Add the oil phase formed in step (1) dropwise into 100-150mL polyvinyl alcohol aqueous solution with a mass fraction of 2%, stir mechanically at 3000rpm for 30min, seal and stand for 30min, then Stir continuously for 3h under the rotating speed of 100°C to form an emulsion;

[0020] (3) Centrifuge the emulsion obtained in step (2), wash the obtained solid with distilled water, centrifuge again, wash, and finally dry in a freeze-vacuum dryer to obtain polycaprolactone-loaded rifapentine microspheres, place Store at -4°C protected from light.

Embodiment 2

[0022] The preparation method of polycaprolactone-loaded rifapentine microspheres comprises the following steps:

[0023] (1) Weigh 34mg of rifapentine technical material and 235mg of polycaprolactone and dissolve them in 13mL of dichloromethane, and perform ultrasonic treatment, wherein the ultrasonic power is 200W, and the ultrasonic time is 30min, to form an oil phase;

[0024] (2) Add the oil phase formed in step (1) dropwise into 100-150mL polyvinyl alcohol aqueous solution with a mass fraction of 2%, stir mechanically at 3000rpm for 30min, seal and stand for 30min, then Stir continuously for 3h under the rotating speed of 100°C to form an emulsion;

[0025] (3) Centrifuge the emulsion obtained in step (2), wash the obtained solid with distilled water, centrifuge and wash again, wherein the centrifugal speed is 1000rpm, the centrifugation time is 30min, and finally dry in a freeze vacuum dryer to obtain poly Caprolactone-loaded rifapentine microspheres were stored at -4°...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a preparation method of rifapentine-carried polycaprolactone microspheres. The preparation method comprises steps as follows: rifapentine crude drugs and polycaprolactone 20 are jointly dissolved in dichloromethane, the mixture is subjected to ultrasonic treatment, and an oil phase is formed; the formed oil phase is dropwise added to a 2% polyvinyl alcohol water solution, mechanically stirred at the rotating speed of 3,000 rpm for 30 min, sealed, left to stand for 30 min and continuously stirred at the rotating speed of 100 rpm for 3 h, and an emulsion is formed; centrifugal treatment is performed, obtained solids are washed with distilled water, centrifugal separation and washing are performed again, finally, drying is performed in a freezing vacuum drier, and the rifapentine-carried polycaprolactone microspheres are obtained and put at the temperature of subzero 4 DEG C in the dark place for storage. The prepared rifapentine-carried polycaprolactone microspheres have round and complete shapes, have a micropore structure on the surface, are good in particle size dispersity and high in drug loading capacity, have a good slow release function and can be used for long-acting interventional therapy of tuberculosis of bones and joints.

Description

technical field [0001] The invention belongs to the field of preparation of drug-loaded microspheres, in particular to a preparation method of polycaprolactone-loaded rifapentine microspheres. Background technique [0002] Bone and joint tuberculosis has seriously affected the health and quality of life of patients for a long time. Oral or intravenous preparations are often used for systemic administration during the treatment process, but it is difficult to achieve effective drug concentrations. Local drugs will disappear quickly with blood circulation and self-metabolism. The local drug loading system can adjust the release rate of the drug, reduce the side effects of the drug, maintain the effective drug concentration for a long time, and improve the curative effect. [0003] Degradable drug-loaded microspheres have been proven to be a highly efficient, low-toxic drug sustained-release control system, and have recently attracted extensive attention from researchers. The...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/50A61K31/496A61K47/34A61P19/08A61P19/02A61P31/06
CPCA61K9/5089A61K9/0002A61K9/5031A61K31/496
Inventor 李长英
Owner SHAANXI YIPINDA PETROCHEM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products